Insider Shareholders with Direct Ownership of Organogenesis Holdings Inc. (ORGO)
This section provides a comprehensive overview of the insiders with direct ownership of Organogenesis Holdings Inc. (ORGO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Organogenesis Holdings Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Alan A. Ades
Director |
20,036,714 | 27,942,648 | 59,836,745 $196 Million | 5 |
May 27, 2021
Reduced 6.1%
|
|
Red Holdings, Llc
> 10% Shareholder |
12,053,457 | 7,392,328 | 59,448,027 $195 Million | 2 |
Dec 28, 2021
Reduced 11.06%
|
|
Albert Erani Family Trust Dated 12/29/2012
> 10% Shareholder |
12,053,457 | 7,796,940 | 59,448,027 $195 Million | 6 |
Dec 28, 2021
Reduced 11.06%
|
|
Dennis Erani
> 10% Shareholder |
5,417,900 | 9,106 | 59,448,027 $195 Million | 2 |
Dec 15, 2021
Added 8.35%
|
|
Dennis Erani 2012 Issue Trust Dated 12/20/12
> 10% Shareholder |
5,417,900 | 0 | 59,448,027 $195 Million | 1 |
Dec 15, 2021
Added 8.35%
|
|
Gn 2016 Organo 10 Year Grat U/A/D September 30, 2016
> 10% Shareholder |
25,000 | 0 | 59,448,027 $195 Million | 1 |
Nov 18, 2021
Added 0.04%
|
|
Glenn H Nussdorf
Director |
20,061,714 | 27,942,648 | 59,448,027 $195 Million | 6 |
Nov 18, 2021
Added 0.04%
|
|
Albert Erani
> 10% Shareholder |
0 | 16,129,860 | 51,585,403 $169 Million | 13 |
Nov 12, 2024
Reduced 4.71%
|
|
Gn 2016 Family Trust U/A/D August 12, 2016
> 10% Shareholder |
0 | 1,000,000 | 51,085,403 $168 Million | 1 |
Nov 27, 2024
Reduced 0.97%
|
|
Gary S. Gillheeney
President and CEO |
5,035,665 | 2,480,927 | 3,039,194 $9.97 Million | 61 |
Dec 16, 2024
Reduced 0.18%
|
|
Patrick Bilbo
Chief Operating Officer |
761,112 | 46,965 | 809,082 $2.65 Million | 15 |
Apr 01, 2024
Reduced 0.31%
|
|
Brian Grow
Chief Commercial Officer |
521,208 | 36,166 | 520,809 $1.71 Million | 14 |
Apr 01, 2024
Reduced 0.38%
|
|
Lori Freedman
Chief Admin. and Legal Officer |
482,596 | 40,242 | 469,272 $1.54 Million | 13 |
Apr 01, 2024
Reduced 0.42%
|
|
David Francisco
Chief Financial Officer |
459,567 | 30,571 | 428,996 $1.41 Million | 11 |
Feb 21, 2024
Added 27.21%
|
|
Wayne D Mackie
Director |
93,236 | 0 | 211,800 $694,704 | 3 |
Feb 16, 2021
Added 2.52%
|
|
Arthur S Leibowitz
Director |
164,047 | 0 | 187,611 $615,364 | 7 |
Feb 21, 2024
Added 21.38%
|
|
Antonio S. Montecalvo
Vice President, Health Policy |
234,307 | 129,105 | 168,268 $551,919 | 16 |
Apr 01, 2024
Reduced 1.03%
|
|
Prathyusha Duraibabu
Director |
148,644 | 0 | 148,644 $487,552 | 4 |
Feb 21, 2024
Added 25.55%
|
|
Jon L Giacomin
Director |
142,623 | 0 | 142,623 $467,803 | 4 |
Feb 21, 2024
Added 26.35%
|
|
Michael Joseph Driscoll
Director |
142,304 | 0 | 142,304 $466,757 | 4 |
Feb 21, 2024
Added 26.39%
|
|
Gilberto Quintero
Director |
140,670 | 0 | 140,670 $461,397 | 3 |
Feb 21, 2024
Added 26.62%
|
|
Michele Ilene Korfin
Director |
140,670 | 0 | 140,670 $461,397 | 3 |
Feb 21, 2024
Added 26.62%
|
|
Robert Cavorsi
Vice President, Strategy |
0 | 317 | 139,766 $458,432 | 1 |
Jul 16, 2024
Reduced 0.23%
|
|
Michael W Katz
> 10% Shareholder |
59,929 | 0 | 76,382 $250,532 | 13 |
Nov 21, 2022
Added 3.78%
|
|
Joshua Alexander Tamaroff
Director |
11,800 | 0 | 30,364 $99,593 | 1 |
Feb 16, 2021
Added 15.29%
|
|
Starr Wisdom
> 10% Shareholder |
0 | 566,297 | 20,000 $65,600 | 8 |
Apr 09, 2021
Reduced 50.0%
|
|
Henry Hagopian Iii
Interim CFO |
10,700 | 0 | 12,073 $39,599 | 1 |
Jan 13, 2021
Added 46.99%
|